Loading people...
Jenna Hebert is an Investment Director on the Venture Team at RA Capital Management, operating out of Boston, Massachusetts. She earned a PhD in Psychiatry from the University of Oxford as a 2016 Rhodes Scholar, following a bachelor's degree in the Biological Basis of Behavior from the University of Pennsylvania. During her undergraduate tenure, she competed as an NCAA athlete and secured a gold medal with the US National Rowing Team at the 2015 World Rowing Under 23 Championships. Transitioning into the institutional finance sector, she now leverages her specialized academic training in neuroscience to evaluate emerging biotechnology and healthcare companies. Her scope involves executing both public and private market investments across the broader healthcare ecosystem. Her current professional focus centers on identifying and supporting early-stage life sciences venture opportunities that drive novel therapeutic developments.
Jenna Hebert is a key Associate at RA Capital, a distinguished multi-stage investment manager focused on public and private companies in the healthcare and life sciences industries. In her capacity as an Associate, Jenna plays a crucial role in the firm's rigorous investment process, contributing significantly to deal sourcing, in-depth due diligence, and comprehensive market analysis. Her work helps identify promising opportunities that align with RA Capital's strategic vision of backing companies poised to revolutionize medicine and patient care.
RA Capital is renowned for its deep scientific expertise and its commitment to fostering innovation across the biotech, pharmaceutical, and medical technology landscapes. Jenna Hebert's investment focus mirrors this commitment, primarily targeting companies developing novel therapeutics, diagnostics, and medical devices. She is particularly interested in early-stage and growth-stage companies that demonstrate strong scientific fundamentals, address significant unmet medical needs, and possess the potential for substantial impact. Her analytical skills are vital in assessing complex scientific data, clinical trial results, and intellectual property landscapes to determine the viability and potential return of prospective investments.
While specific details of Jenna Hebert's career background prior to RA Capital are not publicly detailed, professionals in her role at leading life sciences investment firms typically possess robust academic backgrounds in science, medicine, or finance, often complemented by experience in research, consulting, or investment banking. This foundational expertise equips her to navigate the intricate scientific and commercial challenges inherent in the healthcare sector. Her contributions support RA Capital's broader portfolio, which includes investments in companies at the forefront of gene therapy, oncology, immunology, and rare diseases, among other critical areas.
Jenna's involvement ensures that RA Capital continues to identify and support companies that are not only financially sound but also scientifically compelling. She collaborates closely with RA Capital's team of seasoned investors and scientific advisors, leveraging collective expertise to make informed investment decisions. Her dedication to understanding emerging scientific trends and market dynamics positions her as an important contributor to RA Capital's ongoing success in shaping the future of healthcare. Through her diligent work, Jenna Hebert helps empower innovative companies to translate scientific breakthroughs into tangible health solutions for patients worldwide.
Jenna Hebert is an Associate at RA Capital, a leading multi-stage investment firm focused on the healthcare and life sciences sectors. She plays a key role in evaluating and identifying innovative companies for investment.
Jenna Hebert focuses on investments within the life sciences and healthcare industries. This includes companies developing novel therapeutics, diagnostics, and medical devices across biotechnology, pharmaceuticals, and medical technology.
Jenna Hebert works at RA Capital, a prominent investment manager dedicated to supporting public and private companies in the healthcare and life sciences industries.
